BillionToOne, Inc. BLLN
113.94 USD +1.55 (+1.38%)
At closeNov 6, 2026, 4:00 PM EST
115.26 +1.32 +1.16%
After hours · Nov 6, 4:00 PM ET
106.15 Day range 114.09
64.03 52-week range 149.97
- YTD
- +39.22%
- 1 year
- +4.59%
News
defenseworld.net Insider Selling: Billiontoone (NASDAQ:BLLN) CTO Sells $2,184,800.00 in Stock Billiontoone, Inc. (NASDAQ: BLLN - Get Free Report) CTO David Tsao sold 20,000 shares of the stock in a transaction dated Monday, November 2nd. The shares were sold at an average price of $109.24,…
benzinga.com JP Morgan Maintains Overweight on BillionToOne, Raises Price Target to $135 JP Morgan analyst Casey Woodring maintains BillionToOne (NASDAQ:BLLN) with a Overweight and raises the price target from $130 to $135.
seekingalpha.com BillionToOne, Inc. (BLLN) Q3 2026 Earnings Call Transcript BillionToOne, Inc. (BLLN) Q3 2026 Earnings Call Transcript
zacks.com BillionToOne (BLLN) Reports Q3 Earnings: What Key Metrics Have to Say While the top- and bottom-line numbers for BillionToOne (BLLN) give a sense of how the business performed in the quarter ended September 2026, it could be worth looking at how some of its key metrics…
zacks.com BillionToOne (BLLN) Surpasses Q3 Earnings and Revenue Estimates BillionToOne (BLLN) came out with quarterly earnings of $0.32 per share, beating the Zacks Consensus Estimate of $0.16 per share. This compares to earnings of $0.1 per share a year ago.
marketbeat.com Billiontoone Q3 Earnings Call Highlights Billiontoone NASDAQ: BLLN raised its full-year revenue outlook after third-quarter sales rose 47% from a year earlier, driven by growth in both prenatal and oncology testing. The molecular…
benzinga.com BillionToOne Q3 2026 Earnings Call Transcript BillionToOne (NASDAQ:BLLN) reported third-quarter financial results on Wednesday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to…
benzinga.com BillionToOne Q4 EPS $0.32 Beats $0.28 Estimate, Sales $122.981M Beat $120.146M Estimate BillionToOne (NASDAQ:BLLN) reported quarterly earnings of $0.32 per share which beat the analyst consensus estimate of $0.28 by 14.29 percent. This is a 190.91 percent increase over earnings of $0.11…
benzinga.com BillionToOne Q3 EPS $0.32 Beats $0.19 Estimate, Sales $122.981M Beat $109.365M Estimate BillionToOne (NASDAQ:BLLN) reported quarterly earnings of $0.32 per share which beat the analyst consensus estimate of $0.19 by 68.42 percent. This is a 220 percent increase over earnings of $0.10…- benzinga.com BillionToOne Sees FY2027 Sales $460.000M-$470.000M vs $573.800M Est BillionToOne (NASDAQ:BLLN) sees FY2027 sales of $460.000 million-$470.000 million vs $573.800 million analyst estimate.
globenewswire.com BillionToOne Reports Third Quarter 2026 Results and Raises 2026 Revenue Guidance MENLO PARK, Calif., Nov. 04, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are…- benzinga.com Guggenheim Maintains Buy on BillionToOne, Raises Price Target to $128 Guggenheim analyst Subbu Nambi maintains BillionToOne (NASDAQ:BLLN) with a Buy and raises the price target from $125 to $128.
benzinga.com Medicare Lab Fee Changes Impact BillionToOne, CareDx Differently CMS aligns 2027 clinical lab fees with private payors to save $1 billion, yielding positive updates for CareDx and BillionToOne tests.
benzinga.com Jim Cramer: 'You Could Make Some Money With This 5.6% Yield' Jim Cramer likes Babcock & Wilcox and Smithfield Foods. He also advises taking some profits on BillionToOne, and calls Eton Pharma a winner.
benzinga.com 12 Health Care Stocks Moving In Thursday's Intraday Session Gainers Creative Medical Tech (NASDAQ:CELZ) stock increased by 107.8% to $1.39 during Thursday's regular session. The company's market cap stands at $4.3 million. Ensysce Biosciences (NASDAQ:ENSC)…
benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session Gainers Creative Medical Tech (NASDAQ:CELZ) stock increased by 86.9% to $1.25 during Thursday's pre-market session. The company's market cap stands at $4.3 million. Ensysce Biosciences (NASDAQ:ENSC)…
benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session Gainers Creative Medical Tech (NASDAQ:CELZ) stock moved upwards by 31.4% to $0.88 during Wednesday's after-market session. The company's market cap stands at $4.2 million. Caris Life Sciences…
benzinga.com Jim Cramer: Design Therapeutics Is 'Pure Spec,' Buy This Health Care Stock Cramer likes Silicon Motion, whose shares fell 2.2% to settle at $263.85 on Thursday. Wynn shares declined 0.8% to close at $95.43.
benzinga.com Earnings Scheduled For May 6, 2026 
benzinga.com Joby Aviation Is 'Too Risky,' But This Industrial Stock Is A 'Winner': Jim Cramer Cramer shared his thoughts on various stocks, calling Joby Aviation too risky, BillionToOne a winner, Boston Scientific caught in competition, Rocket Lab a winner, and Pinnacle West Capital a good…- benzinga.com Earnings Scheduled For March 4, 2026
- benzinga.com Earnings Scheduled For December 9, 2025
benzinga.com ServiceTitan Posts Upbeat Q3 Results, Joins DigitalBridge, Rubrik, Victoria's Secret And Other Big Stocks Moving Higher On Friday 
benzinga.com This Joby Aviation Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Monday